Uzun, G. S. Et Al. 2022. IN RHEUMATOID ARTHRITIS PATIENTS RECEIVING BDMARDS, THE CHARLSON COMORBIDITY INDEX IS MORE PRONOUNCED THAN PSORIATIC ARTHRITIS. ANNALS OF THE RHEUMATIC DISEASES , vol.81 , 1265.

Uzun, G. S., Tatar, O. D., Gezerer, N. E., Bilgin, E., Yardimci, G. K., Bolek, E. C., ... Farisogullari, B.(2022). IN RHEUMATOID ARTHRITIS PATIENTS RECEIVING BDMARDS, THE CHARLSON COMORBIDITY INDEX IS MORE PRONOUNCED THAN PSORIATIC ARTHRITIS. ANNALS OF THE RHEUMATIC DISEASES , vol.81, 1265.

Uzun, G. Et Al. "IN RHEUMATOID ARTHRITIS PATIENTS RECEIVING BDMARDS, THE CHARLSON COMORBIDITY INDEX IS MORE PRONOUNCED THAN PSORIATIC ARTHRITIS," ANNALS OF THE RHEUMATIC DISEASES , vol.81, 1265, 2022

Uzun, G. S. Et Al. "IN RHEUMATOID ARTHRITIS PATIENTS RECEIVING BDMARDS, THE CHARLSON COMORBIDITY INDEX IS MORE PRONOUNCED THAN PSORIATIC ARTHRITIS." ANNALS OF THE RHEUMATIC DISEASES , vol.81, pp.1265, 2022

Uzun, G. S. Et Al. (2022) . "IN RHEUMATOID ARTHRITIS PATIENTS RECEIVING BDMARDS, THE CHARLSON COMORBIDITY INDEX IS MORE PRONOUNCED THAN PSORIATIC ARTHRITIS." ANNALS OF THE RHEUMATIC DISEASES , vol.81, p.1265.

@article{article, author={G. Sandal Uzun Et Al. }, title={IN RHEUMATOID ARTHRITIS PATIENTS RECEIVING BDMARDS, THE CHARLSON COMORBIDITY INDEX IS MORE PRONOUNCED THAN PSORIATIC ARTHRITIS}, journal={ANNALS OF THE RHEUMATIC DISEASES}, year=2022, pages={1265} }